Allscripts Healthcare Solutions Management Discusses Q2 2012 Results - Earnings Call Transcript

Allscripts Healthcare Solutions (MDRX)

Q2 2012 Earnings Call

August 08, 2012 4:30 pm ET


Seth Frank - Vice President of Investor Relations

Glen E. Tullman - Chief Executive Officer, Executive Vice President and Director

W. David Morgan - Interim Chief Financial Officer and Senior Vice President of Finance


Michael Cherny - ISI Group Inc., Research Division

Jamie Stockton - Wells Fargo Securities, LLC, Research Division

Atif A Rahim - JP Morgan Chase & Co, Research Division

Gregory T. Bolan - Sterne Agee & Leach Inc., Research Division

Andrew O'Hara

Charles Rhyee - Cowen and Company, LLC, Research Division

George Hill - Citigroup Inc, Research Division

Lawrence C. Marsh - Barclays Capital, Research Division

Alexander Y. Draper - Raymond James & Associates, Inc., Research Division

Eric W. Coldwell - Robert W. Baird & Co. Incorporated, Research Division

Sean W. Wieland - Piper Jaffray Companies, Research Division

Stephen B. Shankman - UBS Investment Bank, Research Division



Good afternoon. My name is Sarah, and I will be your conference operator today. At this time, I would like to welcome everyone to the Second Quarter 2012 Earnings Conference Call. [Operator Instructions] Seth Frank, Vice President of Investor Relations with Allscripts, you may begin your conference.

Seth Frank

Thanks, Sarah. Good afternoon, and thanks for joining us. With me on the call today are Glen Tullman, Allscripts' Chief Executive Officer; Dave Morgan, our interim Chief Financial Officer; and Lee Shapiro, our President.

[Operator Instructions] Before we begin, I'll briefly read the Safe Harbor statement.

If you liked this article you might like

Allscripts Stock Climbs, Cantor Upgrades After McKesson Deal

Analysts' Actions -- Adobe, Starbucks, Snap, KB Home and More

Allscripts (MDRX) Stock Stumbles as Q3 Results Miss Expectations

Analysts' Actions -- Chipotle, Darden, McDonald's, Square and More

Allscripts (MDRX) Stock Lower After Q2 Revenue Miss